Toward a Clinical AI License for Independent Initial Diagnosis and Prescribing in Primary Care
AI · 12.11.2026 · 7 (11) · 480
DOI: 10.3390/ai7110480 ↗Kurz gefasst
Fachartikel in der Zeitschrift AI, online erschienen am 12.11.2026. Verfasst von Yusaku Fujii. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Recent medical large language models have been reported to approach physician-level performance in selected diagnostic and prescribing-related tasks, yet regulations continue to restrict clinical authority to licensed human professionals. Without assuming artificial general intelligence (AGI), I propose a Clinical AI License with four requirements, disease-domain performance thresholds, staged evaluation analogous to clinical trials, graduated scope of practice, and ongoing monitoring, together with an allocation of primary legal liability to the licensed operating entity. Responsibility, empathy, and safety are not fixed human monopolies; under an appropriate licensing framework, they can be specified, evaluated, and continuously monitored in AI-based clinical systems, potentially enabling scalable and more equitable healthcare.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Fujii, Y. (2026). Toward a Clinical AI License for Independent Initial Diagnosis and Prescribing in Primary Care. AI, 7(11), 480. https://doi.org/10.3390/ai7110480
Vancouver
Fujii Y. Toward a Clinical AI License for Independent Initial Diagnosis and Prescribing in Primary Care. AI. 2026;7(11):480. doi:10.3390/ai7110480
BibTeX
@article{Fujii2026,
author = {Fujii, Yusaku},
title = {Toward a Clinical AI License for Independent Initial Diagnosis and Prescribing in Primary Care},
journal = {AI},
year = {2026},
volume = {7},
number = {11},
pages = {480},
doi = {10.3390/ai7110480}
}
EUVIMED